Literature DB >> 9152294

Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation.

V Cormier-Daire1, D Chretien, P Rustin, A Rötig, C Dubuisson, E Jacquemin, M Hadchouel, O Bernard, A Munnich.   

Abstract

Inborn errors of oxidative phosphorylation have been recognized as possible causes of hepatic failure in the neonate, and respiratory enzyme deficiencies have been described in the liver of affected individuals. On the basis of a series of 22 cases, we describe respiratory enzyme deficiency as a cause of early-onset fatal hepatic failure with frequent neurologic involvement. In addition, we have identified a delayed-onset form of hepatic failure with a milder clinical course and inconstant neurologic involvement. Thus we suggest that genetic defects of oxidative phosphorylation be considered as a cause of liver dysfunction in infancy, regardless of the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152294     DOI: 10.1016/s0022-3476(97)80027-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Pulmonary hypertension--a new manifestation of mitochondrial disease.

Authors:  A R Barclay; G Sholler; J Christodolou; A Shun; S Arbuckle; S Dorney; M O Stormon
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

Review 3.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 4.  Clinical presentation of mitochondrial disorders in childhood.

Authors:  A Munnich; A Rötig; D Chretien; V Cormier; T Bourgeron; J P Bonnefont; J M Saudubray; P Rustin
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Secondary Mitochondrial Respiratory Chain Defect Can Delay Accurate PFIC2 Diagnosis.

Authors:  Anne Davit-Spraul; Marine Beinat; Dominique Debray; Agnes Rötig; Abdelhamid Slama; Emmanuel Jacquemin
Journal:  JIMD Rep       Date:  2013-11-09

6.  Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies.

Authors:  F Diaz; S Garcia; D Hernandez; A Regev; A Rebelo; J Oca-Cossio; C T Moraes
Journal:  Gut       Date:  2007-10-19       Impact factor: 23.059

Review 7.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

8.  Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2013-06-28       Impact factor: 4.406

Review 9.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 10.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.